摘要
多糖是公认的免疫调节剂,已被证实对多种癌细胞具有抑制作用,具有开发为抗癌药物的潜力。胰腺癌作为病死率最高的癌症之一,长期采用化疗药物治疗,易产生免疫缺陷、疲劳、神经系统病变等多种副作用。本文总结了国内外多糖类成分抗胰腺癌的研究现状,梳理出多糖类成分可以通过多靶点的作用方式,调控核因子κB、Hippo-转录共激活因子相关蛋白、整合素等相关信号通路,诱导癌细胞凋亡、自噬,抑制癌细胞增殖、迁移与侵袭,调控癌细胞周期,从而发挥抗胰腺癌的作用。
Polysaccharide is a recognized immunomodulator that has been shown to have inhibitory effects on a variety of cancer cells and has the potential to be developed as an anti-cancer drug. Pancreatic cancer, one of the cancers with the highest mortality rate, is treated with long-term chemotherapeutic drugs and is prone to a variety of side effects such as immune deficiency, fatigue, and neurological lesions. The polysaccharide anti-pancreatic cancer research landscape both domestically and internationally is summarized in this publication. By regulating nuclear factor-κB, Hippo-Yes-associated protein, integrin and other signaling pathways, polysaccharide components play an anti-pancreatic cancer role by multi-target ways, such as inducing apoptosis and autophagy, inhibiting proliferation, migration and invasion of cancer cells, and regulating the cancer cell cycle.
作者
刘光宇
王琦
苏玲
LIU Guangyu;WANG Qi;SU Ling(Engineering Research Center of Chinese Ministry of Education for Edible and Medicinal Fungi,Jilin Agricultural University,Changchun 130118,China;College of Chinese Materia Medica,Jilin Agricultural University,Changchun 130118,China;College of Plant Protection,Jilin Agricultural University,Changchun 130118,China)
出处
《中国药房》
CAS
北大核心
2023年第1期111-116,共6页
China Pharmacy
基金
国家重点研发计划项目(No.2021YFD1600401)
国家现代农业技术体系项目(No.CARS-20)
灵芝多糖药理活性研究项目(No.横20200061)。
关键词
多糖
胰腺癌
作用机制
polysaccharide
pancreatic cancer
effect mechanism